|
|
 |
|
MORPINE SULPHATE® (Injectable Formulation) relieves moderate to severe pain by binding to brain receptors. Morphine Sulphate may be used to control the pain following surgery, child birth, and other procedures. It may also be used to treat the pain associated with cancer, heart attacks, sickle cell disease and other medical conditions. On January 1, 2007, Samaritan entered into an exclusive licensing agreement with Molteni Farmaceutici for the marketing and distribution of MORPHINE SULPHATE® in the countries of Greece and Cyprus. Currently, MORPHINE SULPHATE®
can only be sold in Greece and Cyprus via a centralized government
tender. Samaritan is preparing a tender application for the next
request by Greek authorities for applications. |
Welcome
to theThis Web site is intended and designed specifically for healthcare professionals from Greece and Cyprus only.
| About
Morphine Sulphate | Indications
for Use | Dosage and Administration
| Samaritan Pharmaceuticals
|
| Prescribing Information
(PDF) | Safety Information | Contact
Us | Resources | Home
|